ZA200502693B - Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof. - Google Patents

Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof. Download PDF

Info

Publication number
ZA200502693B
ZA200502693B ZA200502693A ZA200502693A ZA200502693B ZA 200502693 B ZA200502693 B ZA 200502693B ZA 200502693 A ZA200502693 A ZA 200502693A ZA 200502693 A ZA200502693 A ZA 200502693A ZA 200502693 B ZA200502693 B ZA 200502693B
Authority
ZA
South Africa
Prior art keywords
excipient
pharmaceutical
pores
mean width
primary
Prior art date
Application number
ZA200502693A
Other languages
English (en)
Inventor
Michael Tobyn
John Nicholas Staniforth
Cheryl Clinch
Matthew Paul Hearn
Dominic Walsh
Simon Robert Hall
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of ZA200502693B publication Critical patent/ZA200502693B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02Dextran; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200502693A 2002-10-11 2005-04-04 Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof. ZA200502693B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41805502P 2002-10-11 2002-10-11

Publications (1)

Publication Number Publication Date
ZA200502693B true ZA200502693B (en) 2005-10-24

Family

ID=32094142

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200502693A ZA200502693B (en) 2002-10-11 2005-04-04 Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof.

Country Status (9)

Country Link
US (1) US20060127480A1 (ko)
EP (1) EP1549294A1 (ko)
JP (1) JP2006506357A (ko)
KR (1) KR20050089961A (ko)
AU (1) AU2003269284A1 (ko)
CA (1) CA2500923A1 (ko)
NZ (1) NZ539277A (ko)
WO (1) WO2004032901A1 (ko)
ZA (1) ZA200502693B (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0109384D0 (en) * 2001-04-12 2001-05-30 Vectura Ltd Pharmaceutical products, preparation and uses thereof
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
MX2007007373A (es) * 2004-12-20 2007-08-14 Australian Nuclear Science Tec Liberacion controlada de entidades biologicas.
WO2007144894A1 (en) * 2006-06-15 2007-12-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Hydrocolloid carrier beads with inert filler material
US8066770B2 (en) * 2007-05-31 2011-11-29 Depuy Products, Inc. Sintered coatings for implantable prostheses
EP2282726A1 (en) * 2008-05-15 2011-02-16 Firmenich S.A. Delivery system for an active ingredient
AU2009316876A1 (en) * 2008-11-20 2011-07-07 Avantor Performance Materials, Inc. Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
WO2010102066A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Dextran polymer powder for inhalation administration of pharmaceuticals
US7829513B2 (en) * 2009-03-12 2010-11-09 Greenology Products, Inc. Organic cleaning composition
US9724664B2 (en) 2009-03-27 2017-08-08 Bend Research, Inc. Spray-drying process
WO2011146858A2 (en) * 2010-05-21 2011-11-24 President And Fellows Of Harvard College Foams, including microcellular foams, containing colloidal particulates
US20130202657A1 (en) * 2010-05-21 2013-08-08 Basf Se Foams or particles for applications such as drug delivery
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
KR101268883B1 (ko) * 2010-12-06 2013-05-29 한국세라믹기술원 미네랄브릿지 구조를 갖는 고강도 유무기 복합체 및 이의 제조방법
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
US10398905B2 (en) * 2012-02-19 2019-09-03 Nvigen, Inc. Uses of porous nanostructure in delivery
EP2836083B1 (en) 2012-04-10 2016-08-03 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG Wet granulation process and granulate material comprising arabic gum
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
US9790331B2 (en) * 2013-08-29 2017-10-17 Evonik Roehm Gmbh Process for preparing a bio-resorbable polyester in the form of a powder
TWI658842B (zh) * 2014-03-31 2019-05-11 日商東麗股份有限公司 固體製劑用之被覆劑以及由其所形成之被膜及被覆固體製劑
KR20160137626A (ko) 2014-03-31 2016-11-30 메사추세츠 인스티튜트 오브 테크놀로지 제약상 활성 종을 포함하는 화합물을 함유한 다공성 물질
EP3212169B1 (en) 2014-10-31 2021-01-13 Bend Research, Inc. Process for forming active domains dispersed in a matrix
US20160279246A1 (en) * 2015-02-27 2016-09-29 Massachusetts Institute Of Technology Methods and systems for continuous heterogeneous crystallization
CA3036356A1 (en) 2016-09-09 2018-03-15 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen
DE102018102365A1 (de) * 2018-02-02 2019-08-08 Dr. Kurt Wolff Gmbh & Co. Kg Hydroxylapatit
CA3107696A1 (en) * 2018-10-04 2020-04-09 Chemische Fabrik Budenheim Kg Spherical beads for use in producing pharmaceutically active pellets
EP3892262A1 (en) * 2020-04-06 2021-10-13 Chemische Fabrik Budenheim KG Beads comprising a buffer system
CN112957375B (zh) * 2021-04-07 2023-04-07 江西师范大学 高亲和性虾壳钙粉及其制备方法和在制备用于治疗缺钙性症状和/或疾病的药物中的应用
WO2024029516A1 (ja) * 2022-08-01 2024-02-08 東和薬品株式会社 多孔質キャリア粒子、機能性成分担持粒子及び多孔質キャリア粒子の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933372A (en) * 1988-09-26 1990-06-12 Supelco, Inc. Porous rigid resins and process of preparation
FR2638234B1 (fr) * 1988-10-21 1992-11-27 Rhone Poulenc Chimie Support pour molecules biologiquement actives ou lui-meme biologiquement actif, son procede de preparation et son application en biologie
US6471993B1 (en) * 1997-08-01 2002-10-29 Massachusetts Institute Of Technology Three-dimensional polymer matrices

Also Published As

Publication number Publication date
AU2003269284A1 (en) 2004-05-04
EP1549294A1 (en) 2005-07-06
US20060127480A1 (en) 2006-06-15
KR20050089961A (ko) 2005-09-09
CA2500923A1 (en) 2004-04-22
WO2004032901A1 (en) 2004-04-22
JP2006506357A (ja) 2006-02-23
NZ539277A (en) 2008-04-30

Similar Documents

Publication Publication Date Title
ZA200502693B (en) Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof.
JP2006506357A6 (ja) 有機高分子物質との組み合わせで無機粒子を含み、かつ固体の網目状マトリックスを形成する医薬賦形剤、その組成物、製造および使用
US9295653B2 (en) Controlled agglomeration
KR101380088B1 (ko) 약학 조성물
KR100415897B1 (ko) 생체 이용율이 높은 페노피브레이트 제약학적 조성물
AU2002325192A1 (en) Controlled agglomeration
JP7124107B2 (ja) 多孔性シリカ粒子組成物
US20030129244A1 (en) Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations
US20060013871A1 (en) Intimate coating of ibuprofen with poloxamers to enhance aqueous dissolution
US20040091544A1 (en) Coated dibasic calcium phosphate
EP2637643B1 (en) Pharmaceutical composition for treating hcv infections
JP2010513324A (ja) 医薬化合物および医薬組成物
US20230372345A1 (en) Inhaled PDE-V Inhibitor Drugs
KR20180035723A (ko) 라코사미드 서방성 제제
WO2021136089A1 (zh) 一种抗肿瘤药物组合物以及提高化合物的溶解度的方法
WO2022235750A1 (en) Delivery of cellular material and other material as a dry powder